Antares Pharma, Inc. today announced that an abstract on XYOSTED ® , a subcutaneous testosterone enanthate injection, was accepted as on oral presentation at the 22nd Annual Fall Scientific Meeting of SMSNA in Scottsdale, AZ on October 21-24, 2021.
October 25, 2021
· 9 min read